期刊文献+

血清超敏C-反应蛋白水平与冠心病的关系探讨 被引量:2

Detection of high sensitive c-reaction protein in patients with coronary heart disease
下载PDF
导出
摘要 目的探讨冠心病(CHD)患者超敏C反应蛋白(HS-CRP)水平差异及其与血脂的关系。方法 138例冠心病和164例冠脉造影正常的非冠心病患者,分别测定了HS-CRP、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、胆固醇(TC)和低密度脂蛋白胆固醇(LIDL-C)血清水平,并进行相关性分析。结果 CHD组血清HS-CRP水平为(4.77±3.24)mg/L,与非CHD组的(2.72±1.43)mg/L相比较,差异无统计学意义(P=0.068),但CHD组高HS-CRP水平发生率(44.93%)远高于非CHD组(19.51%)(P<0.01);HS-CRP与TG具有相关性(r=0.551,P=0.003)最强。结论冠心病患者可能存在隐性炎症;HS-CRP检测对了解冠心病患者血管内皮功能有一定的意义。 Objective To detect the level of HS - CRP in patients with coronary heart disease(CHD),and its relations to other risk factors.Methods The serum levels of high - sensitive CRP(HS - CRP) in patients with CHD and non -CHD were measured by immunoturbidimetry,while triglycer ide(TG),high - density lipoprotein cholesterol(HDL - C),total cholesterol(TC),low -density lipoprotein cholesterol(LDL - C) were measured by enzymatic analysis.Results There were no statistical differences between serum levels of HS - CRP in CHD and non - CHD(P =0.068),but the percentage of patients with high HS - CRP in patients with CHD were much higher than those in non - CHD(P <0.01 ).HS - CRP was more relative to TG than other risk factors(r =0.551,P =0.003).Conclusion The patients with CHD may exsit potential in flammation.HS - CRP can be regarded as an independent risk factor of CHD,and detection of HS - CRP have diagnostic value to understand vascular epithelial function in patients with CHD.
出处 《中国医学创新》 CAS 2011年第35期23-25,共3页 Medical Innovation of China
关键词 C反应蛋白质 冠状动脉疾病 血脂 C-Reactive protein Coronary disease Lipids blood
  • 相关文献

参考文献6

  • 1Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations [J]. Int J Pharm, 1997, 154 (2): 123-140.
  • 2Ridker PM,Cushman M,Stampfer MJ,et al.Inf lammation,aspirin and the risk of cardiovascular disease in apparently healthy men[J].N Eng J Med,1997,336:973-979.
  • 3Yudkin JS,Schalk CG,Kuller LH,et al.Plasma concentration of C-react ive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endotheial dysfunction:evidence for chronic inflammat ion[J].Diabetologia,1999,42:351-357.
  • 4Cleland JL, Jones AJS. Stable formulation of recombinant human growth hormone and interferon gamma for microencapsulation in biodegradable microspheres [J]. Pharr Res, 1996,13(10): 1464-1475.
  • 5Zhang X, Jackson JK, Burt HM. Development of amphiphilic diblock copolymers as micellar carriers of taxol[J]. Int J Pharm, 1996, 132(1, 2): 195-206.
  • 6Allen C, Eisenberg A, Maysinger D. Nano-engineering block copolymer aggregates for drug delivery [J]. Colloids Surf B Biointerfaces, 1999, 16 (1): 3-27.

共引文献1

同被引文献16

  • 1Disciascio G,Patti G,Pasceri V,et al.Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention:results of the ARMYDA-RECAPTURE(Atorvastatin for reduction of myocardial damage during angioplasty)randomized trial[J].J Am Coll Cardiol,2009,54(6):558-565.
  • 2Patti G,Pasceri V,Colonna G,et al.Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early precutaneous coronary intervention:results of the ARMY-DA-ACS randomized trial[J].J Am Coll Cardiol,2007,49(12):1272-1278.
  • 3Nusca A,Melfi R,Patti G,et al.Statin loading for acute coronary syndromes[J].Curr Opin Cardiol,2010,25(4):373-378.
  • 4Kiyici A,Mehmetoglu I,Karaoglan H,et al.Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis:does albumin analysis rnethod affect albumin-adjusted ischemia-modified albumin levels?[J].J Clin Lab Anal,2010,24(4):273-277.
  • 5Lee D H,Jeon H K,Park H J,et al.Change in ischemia-modified albumin and its clinical significance during exercise stress testing[J].Circ J,2010,74(3):484-489.
  • 6Otake H,Shite J,Shinke T,et al.Relation between plasma adiponectin,high-sensitivity C-reactive protein,and coronary plaque components in patients with acute coronary syndrome[J].Am J Cardiol,2008,101(1):1-7.
  • 7Briguori C,Visconti G,Focaccio A,et al.Novel approaches for preventing or limiting events(Naples)Ⅱtrial:impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction[J].J Am Coil Cardiol,2009,54(23):2157.
  • 8黄虹,李红,郑芬萍,卢薇娜,董雪红,阮昱.老年与非老年2型糖尿病患者肾脏损害的特点及影响因素[J].中华医学杂志,2010,90(14):967-971. 被引量:5
  • 9陈素芳,李华,李天艺,焦文君,陈英伟,岳欣阁,李伟芳,冯明,杨再刚,赵艳艳,田勇.老年2型糖尿病患者动态血糖监测分析[J].中华老年医学杂志,2011,30(7):569-573. 被引量:15
  • 10霍素华.血脂检验对糖尿病的临床意义分析[J].中国医学创新,2011,8(27):171-172. 被引量:19

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部